Maria Das Graças Carvalho

Dr. Maria Das Graças Carvalho


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2019 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
MSMarcos Vinícius Ferreira Silva
Marcos Vinícius Ferreira Silva
CLCristina de Mello Gomide Loures
Cristina de Mello Gomide Loures
LALuan Carlos Vieira Alves
Luan Carlos Vieira Alves
LSLeonardo Cruz de Souza
Leonardo Cruz de Souza
KBKarina Braga Borges
Karina Braga Borges
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho
Alzheimer’s disease (AD) is the most common type of dementia and typically manifests through a progressive loss of episodic memory and cognitive function, subsequently causing language and visuospatial skills deficiencies, which are often accompanied by behavioral disorders such as apathy, aggressiveness and depression. The presence of extracellular plaques of insoluble β-amyloid peptide (Aβ) and neurofibrillary tangles (NFT) containing hyperphosphorylated tau protein (P-tau) in the neuronal cytoplasm is a remarkable pathophysiological cause in patients’ brains. Approximately 70% of the risk of developing AD can be attributed to genetics. However, acquired factors such as cerebrovascular diseases, diabetes, hypertension, obesity and dyslipidemia increase the risk of AD development. The aim of the present minireview was to summarize the pathophysiological mechanism and the main risk factors for AD. As a complement, some protective factors associated with a lower risk of disease incidence, such as cognitive reserve, physical activity and diet will also be addressed.

1 July 2017 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
RDRita Carolina Figueiredo Duarte
Rita Carolina Figueiredo Duarte
CFCláudia Natália Ferreira
Cláudia Natália Ferreira
DRDanyelle Romana Alves Rios
Danyelle Romana Alves Rios
HRHelton José dos Reis
Helton José dos Reis
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho
The existing techniques to evaluate hemostasis in clinical laboratories are not sensitive enough to detect hypercoagulable and mild hypocoagulable states. Under different experimental conditions, the thrombin generation test may meet these requirements. This technique evaluates the overall balance between procoagulant and anticoagulant forces and has provided new insights in our understanding of the coagulation cascade, as well as of the diagnosis of hypocoagulability and hypercoagulability conditions. Thrombin generated in the thrombin generation test can be quantified as platelet-rich or platelet-poor plasma using the calibrated automated thrombogram method, which monitors the cleavage of a fluorogenic substrate that is simultaneously compared to the known thrombin activity in a non-clotting plasma sample. The calibrated automated thrombogram method is an open system, in which different antibodies, proteins, enzymes and peptides can be introduced to answer specific questions regarding hemostatic processes. The thrombin generation test has great clinical potential, such as in monitoring patients taking anticoagulants and antiplatelet drugs, screening for genetic or acquired thrombotic disorders, and evaluating bleeding risk control in patients with hemophilia using bypass agents or replacement therapy. Different to conventional coagulation tests, the thrombin generation test can be used for an overall evaluation of hemostasis, the results of which can then be used to evaluate specific characteristics of hemostasis, such as prothrombin time, activated partial thromboplastin time, and levels of fibrinogen and other coagulation factors. The introduction of this method will contribute to a better understanding and evaluation of overall hemostatic processes; however, this method still requires standardization and clinical validation.

30 October 2009 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
ABA. P. B. Batschauer
A. P. B. Batschauer
CFClaudia pinto Figueiredo
Claudia pinto Figueiredo
EBE. C. Bueno
E. C. Bueno
MRM. A. Ribeiro
M. A. Ribeiro
LDL. M. S. Dusse
L. M. S. Dusse
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho
Background: Breast cancer is the most common cause of death in women by neoplasia. The mechanisms related to recurrence are unclear, specially the hemostatic alterations that occur during the development of the disease. Plasma D-dimer is a hypercoagulability and fibrinolytic system marker and is increased in patients with various solid tumors. The purpose of this study was to evaluate the hemostatic status assessed by plasma D-dimer in operable breast cancer patients and to investigate its value as a prognostic marker. Materials and methods: The study comprised 32 patients with operable hormone receptor-negative breast cancer and a control group with 43 healthy women. Variables included presence and absence of breast cancer, clinical and histopathology findings, and overall survival. Results: Plasma D-dimer level was normal in the control group and significantly higher in breast cancer patients (P = 0.001), as well as in nonsurvivors compared with survivors (P = 0.025). The results showed that plasma D-dimer levels were not correlated with clinical and histopathology findings (P > 0.213). Conclusions: The results taken together indicate the presence of a hypercoagulability state in women with operable hormone receptor-negative breast cancer given the increased levels of D-dimer in this group. Therefore, considering higher levels of D-dimer in patients with a poor outcome, its evaluation may be a promising tool for prognosis in women with operable hormone receptor-negative breast cancer.

4 September 2024 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
LCLiana Cristina Melo Carneiro Costa
Liana Cristina Melo Carneiro Costa
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho
FVFilipa F. Vale
Filipa F. Vale
AMAndreia Tomás Marques
Andreia Tomás Marques
LRLucas Rasmussen
Lucas Rasmussen
MBMelina Barros-Pinheiro
Melina Barros-Pinheiro
The oral cavity may play a role as a reservoir and in the transmission and colonization of Helicobacter pylori. The route of transmission for H. pylori is not fully understood. The prevalence of this pathogen varies globally, affecting half of the world’s population, predominantly in developing countries. Here, we review the prevalence of H. pylori in the oral cavity, the characteristics that facilitate its colonization and dynamics in the oral microbiome, the heterogeneity and diversity of virulence of among strains, and noninvasive techniques for H. pylori detection in oral samples. The prevalence of H. pylori in the oral cavity varies greatly, being influenced by the characteristics of the population, regions where samples are collected in the oral cavity, and variations in detection methods. Although there is no direct association between the presence of H. pylori in oral samples and stomach infection, positive cases for gastric H. pylori frequently exhibit a higher prevalence of the bacterium in the oral cavity, suggesting that the stomach may not be the sole reservoir of H. pylori. In the oral cavity, H. pylori can cause microbiome imbalance and remodeling of the oral ecosystem. Detection of H. pylori in the oral cavity by a noninvasive method may provide a more accessible diagnostic tool as well as help prevent transmission and gastric re-colonization. Further research into this bacterium in the oral cavity will offer insights into the treatment of H. pylori infection, potentially developing new clinical approaches.

1 January 2019 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
PDF file
MBMaria Aparecida Beserra
Maria Aparecida Beserra
DCDiene Carlos
Diene Carlos
MLMaria Neto da Cruz Leitão
Maria Neto da Cruz Leitão
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho
Objective: to analyze the school violence suffered and practiced and its association with the use of alcohol and other drugs in adolescents between 12 and 18 years old. Method: the study sample consisted of 643 adolescents enrolled in six schools, who answered two self-administered questionnaires: “Global School-based Student Health Survey” and “Violence in School”. Statistical analysis was performed using the chi-square test and the degree of association between the variables was analyzed using the prevalence ratio. Results: the prevalence of school violence suffered and practiced was 62.2% and 51.9%, respectively. About 44.6% of the aggressors said they did not want to change their behavior. There was an expressive prevalence of alcohol use (16.5%), tobacco (15.7%) and illicit drugs (6.8%), and drunkenness (12.6%). There was a significant association between the violence suffered and the age group of 12 to 14 years old (p=0.001); (p=0.011) and education level in elementary school (p<0.001). In mothers with less than eight years of studies, the association was significant for the violence practiced (p=0.002). Conclusion: the study contributes to the aspects involved in school violence, which can subsidize actions and policies in this area.

27 November 2007 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
ASAdriano Sabino
Adriano Sabino
AFAna Paula Fernandes
Ana Paula Fernandes
LLLuciana Moreira Lima
Luciana Moreira Lima
DRDaniel Dias Ribeiro
Daniel Dias Ribeiro
MSMarinez Oliveira Sousa
Marinez Oliveira Sousa
MCMaria Das Graças Carvalho
Maria Das Graças Carvalho